Literature DB >> 15686239

The pathogenesis of discogenic low back pain.

B Peng1, W Wu, S Hou, P Li, C Zhang, Y Yang.   

Abstract

Discogenic low back pain is a common cause of disability, but its pathogenesis is poorly understood. We collected 19 specimens of lumbar intervertebral discs from 17 patients with discogenic low back pain during posterior lumbar interbody fusion, 12 from physiologically ageing discs and ten from normal control discs. We investigated the histological features and assessed the immunoreactive activity of neurofilament (NF200) and neuropeptides such as substance P (SP) and vasoactive-intestinal peptide (VIP) in the nerve fibres. The distinct histological characteristic of the painful disc was the formation of a zone of vascularised granulation tissue from the nucleus pulposus to the outer part of the annulus fibrosus along the edges of the fissures. SP-, NF- and VIP-immunoreactive nerve fibres in the painful discs were more extensive than in the control discs. Growth of nerves deep into the annulus fibrosus and nucleus pulposus was observed mainly along the zone of granulation tissue in the painful discs. This suggests that the zone of granulation tissue with extensive innervation along the tears in the posterior part of the painful disc may be responsible for causing the pain of discography and of discogenic low back pain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686239

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  82 in total

Review 1.  Treatment of chronic low back pain with botulinum neurotoxins.

Authors:  Bahman Jabbari
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 2.  Evidence based medicine in the use of botulinum toxin for back pain.

Authors:  B Jabbari
Journal:  J Neural Transm (Vienna)       Date:  2008-03-25       Impact factor: 3.575

Review 3.  Advances in the diagnosis of degenerated lumbar discs and their possible clinical application.

Authors:  Marco Brayda-Bruno; Marta Tibiletti; Keita Ito; Jeremy Fairbank; Fabio Galbusera; Alberto Zerbi; Sally Roberts; Ellen Wachtel; Yulia Merkher; Sarit Sara Sivan
Journal:  Eur Spine J       Date:  2013-08-27       Impact factor: 3.134

4.  Intervertebral discs from spinal nondeformity and deformity patients have different mechanical and matrix properties.

Authors:  Kevin K Cheng; Sigurd H Berven; Serena S Hu; Jeffrey C Lotz
Journal:  Spine J       Date:  2013-11-15       Impact factor: 4.166

Review 5.  What is the clinical evidence on regenerative medicine in intervertebral disc degeneration?

Authors:  M Basso; L Cavagnaro; A Zanirato; S Divano; C Formica; M Formica; L Felli
Journal:  Musculoskelet Surg       Date:  2017-02-13

6.  Low back pain associated with lumbar disc herniation: role of moderately degenerative disc and annulus fibrous tears.

Authors:  Hao Yang; Hui Liu; Zemin Li; Kuibo Zhang; Jianru Wang; Hua Wang; Zhaomin Zheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

7.  Percutaneous treatment of cervical disk hernias using gelified ethanol.

Authors:  J Theron; H Cuellar; T Sola; L Guimaraens; A Casasco; P Courtheoux
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

8.  Diagnosis and surgical treatment of back pain originating from endplate.

Authors:  Baogan Peng; Jindong Chen; Zengda Kuang; Duanming Li; Xiaodong Pang; Xinyu Zhang
Journal:  Eur Spine J       Date:  2009-03-18       Impact factor: 3.134

9.  Biomechanical testing of a polymer-based biomaterial for the restoration of spinal stability after nucleotomy.

Authors:  Aldemar A Hegewald; Sven Knecht; Daniel Baumgartner; Hans Gerber; Michaela Endres; Christian Kaps; Edgar Stüssi; Claudius Thomé
Journal:  J Orthop Surg Res       Date:  2009-07-15       Impact factor: 2.359

10.  Expression of semaphorin 3A and its receptors in the human intervertebral disc: potential role in regulating neural ingrowth in the degenerate intervertebral disc.

Authors:  Sotonye K Tolofari; Stephen M Richardson; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2010-01-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.